About this trial
The aim of this clinical trial is to determine the effects of su jok seed therapy on pain, anxiety and psychological resilience in patients hospitalized in the oncology ward. This study seeks answers to the following questions; Does su jok seed therapy affect the pain levels of cancer patients? Does su jok seed therapy affect the anxiety levels of cancer patients? Does su jok seed therapy affect the Psychological resilience levels of cancer patients? There will be an experimental and control group in the study and the effectiveness of sujok application will be examined.
A total of 8 sessions of su jok seed therapy will be applied to the experimental group, twice a week for a month. No intervention will be made to the control group.
Individuals over 18 years old, without communication problems and diagnosed with cancer will be included in the sample.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Being over 18 years old,
No communication problems,
Individuals diagnosed with cancer
Disqualifiers
Getting worse or dying during the research process
Trial design
Crossover
Treatments tested in this trial
Su-Jok
DeviceSu-jok seed therapy
Treatment groups
Trial outcomes
Primary outcomes
Pain levels of cancer patients will be evaluated using VAS.
Pain levels of cancer patients
Anxiety levels of cancer patients will be evaluated using the "State Anxiety Scale".
Anxiety levels of cancer patients
Psychological resilience levels of cancer patients will be evaluated using the "Brief Psychological Resilience Scale".
Psychological resilience levels of cancer patients
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: